Bruker Corporation (BRKR)
Bruker Corporation (BRKR) is a global leader in scientific instrumentation and analytical solutions. It specializes in high-performance tools for molecular and materials research, including mass spectrometry, nuclear magnetic resonance (NMR), and other analytical techniques. The company's products are widely used in healthcare, pharmaceuticals, academia, and industrial research to support scientific discovery and quality control.
Dividend History
Investors can expect a dividend payout of $0.05 per share, scheduled to be distributed in 13 days on October 3, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 3, 2025 | $0.05 | 2025-09-23 | 2025-09-23 |
| June 27, 2025 | $0.05 | 2025-06-16 | 2025-06-16 |
| March 28, 2025 | $0.05 | 2025-03-17 | 2025-03-17 |
| December 16, 2024 | $0.05 | 2024-12-02 | 2024-12-02 |
| September 16, 2024 | $0.05 | 2024-08-30 | 2024-09-02 |
Dividends Summary
- Bruker Corporation has issued 39 dividend payments over the past 9 years
- The most recent dividend was paid 85 days ago, on June 27, 2025
- The highest dividend payed out to investors during this period was $0.05 per share
- The average dividend paid during this period was $0.04 per share.
Company News
Medical device company Bruker announced a $600 million mandatory convertible preferred stock offering to retire debt, causing an 11.68% stock price decline on Wednesday.
The Atomic Spectroscopy Market is projected to grow from USD 1.57 Billion in 2024 to USD 2.37 Billion by 2032, with a CAGR of 5.28%, driven by increasing demand for precise elemental analysis in pharmaceuticals, environmental monitoring, and food safety.
Wall Street indices extended record highs on strong earnings and investor confidence, with gold prices surging to $3,400 amid dollar weakness and speculation about Federal Reserve leadership.
The Instruments - Scientific industry is benefiting from increasing healthcare spending, driven by aging demography, and continued innovation in the pharma and life sciences end markets. Mettler-Toledo and Bruker are gaining from the growing testing needs of newer biological drugs and the increasing demand for automated solutions.
